Association of Newer Glucose‐Lowering Medications and Phenoconversion From REM Sleep Behaviour Disorder to Parkinsonian Disorders in Older Adults with Type 2 Diabetes
Journal of Sleep Research · 18.11.2026
DOI: 10.1111/jsr.70490 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Sleep Research, online erschienen am 18.11.2026. Verfasst von Michael F. Presti und 10 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health.
Themen: Diabetes mellitus, Gerontologische Pflege
Abstract (Originalsprache)
It has been estimated that as many as 90% of patients with isolated REM behaviour disorder (iRBD) develop an α‐synucleinopathy, yet there are currently no treatments proven to prevent or to delay phenoconversion. This study evaluated the association between glucose‐lowering drug classes and incident Parkinson’s disease (PD), parkinsonism, and dementia with Lewy bodies (DLB) among older adults with RBD and type 2 diabetes (T2D). We conducted a target trial emulation using a retrospective active‐comparator new‐user design with 2016‐2020 Medicare fee‐for‐service claims data amongst beneficiaries ≥ 66 years with RBD and T2D and atleast 12 months of continuous enrollment before treatment initiation. We identified initators of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs), dipeptidyl peptidase‐4 inhibitors (DPP‐4is) or sodium‐glucose cotransporter‐2 inhibitors (SGLT‐2is). Patients with prior use of either drug during the 12‐month baseline period or initiation of both drugs on the index date were excluded. Hazard ratios for incident PD, parkinsonism or DLB were estimated using Cox proportional hazards models with stabilized inverse probability of treatment weighting. Hazard ratios were estimated using Cox proportional regression models with inverse probability of treatment weighting. A total of 148, 144 and 138 patients were included in the GLP‐1RA versus DPP‐4i, GLP‐1RA versus SGLT‐2i and SGLT‐2i versus DPP‐4i cohorts, respectively. Compared with DPP‐4i use, GLP‐1RA use was associated with a lower risk of PD (HR, 0.02; 95% CI, 0.001–0.20), parkinsonism (HR, 0.08; 95% CI, 0.01–0.96) and the PD or parkinsonism composite (HR, 0.11; 95% CI, 0.01–0.83), but not DLB (HR, 0.45; 95% CI, 0.04–5.37). Similarly, compared with DPP‐4i use, SGLT‐2i use was associated with a lower risk of PD (HR, 0.03; 95% CI, 0.001–0.97), parkinsonism (HR, 0.02; 95% CI, 0.001–0.87), and their composite (HR, 0.02; 95% CI, 0.001–0.86), but not DLB (HR, 0.94; 95% CI, 0.17–5.17). No statistically significant differences were observed between GLP‐1RA and SGLT‐2i users. Amongst older adults with RBD and T2D, the risk of incident PD and parkinsonism differed by class of GLDs. Use of GLP‐1RAs or SGLT‐2is was associated with a lower risk of PD and parkinsonism compared with DPP‐4is, while no significant differences were observed for DLB. No statistically significant differences were observed between GLP‐1RAs and SGLT‐2is. These findings warrant confirmation in studies with longer follow‐up and larger sample sizes.
Förderung
- National Institutes of Health
Zitieren
APA
Presti, M. F., Kotecha, P., Lahijani, M., Vallaincourt, D., Jaffee, M., Okun, M. S., Ramirez‐Zamora, A., Mehrad, B., Donahoo, W. T., Bian, J., & Guo, J. (2026). Association of Newer Glucose‐Lowering Medications and Phenoconversion From REM Sleep Behaviour Disorder to Parkinsonian Disorders in Older Adults with Type 2 Diabetes. Journal of Sleep Research. https://doi.org/10.1111/jsr.70490
Vancouver
Presti MF, Kotecha P, Lahijani M, Vallaincourt D, Jaffee M, Okun MS, et al. Association of Newer Glucose‐Lowering Medications and Phenoconversion From REM Sleep Behaviour Disorder to Parkinsonian Disorders in Older Adults with Type 2 Diabetes. Journal of Sleep Research. 2026. doi:10.1111/jsr.70490
BibTeX
@article{Presti2026,
author = {Presti, Michael F. and Kotecha, Pareeta and Lahijani, Majid and Vallaincourt, David and Jaffee, Michael and Okun, Michael S. and Ramirez‐Zamora, Adolfo and Mehrad, Borna and Donahoo, William T. and Bian, Jiang and Guo, Jingchuan},
title = {Association of Newer Glucose‐Lowering Medications and Phenoconversion From REM Sleep Behaviour Disorder to Parkinsonian Disorders in Older Adults with Type 2 Diabetes},
journal = {Journal of Sleep Research},
year = {2026},
doi = {10.1111/jsr.70490}
}
EUVIMED